MiniMax vs PostEra
MiniMaxGenerative AI Platforms
From $0.30 / 1M input tokensPublished price
PostEraDrug Discovery Platforms
CustomPublished price
MiniMax Generative AI Platforms Co-create intelligence with everyone | PostEra Drug Discovery Platforms Medicinal Chemistry Powered by Machine Learning | |
|---|---|---|
| Overview | ||
| Category | Generative AI Platforms | Drug Discovery Platforms |
| What it is | Chinese AI company developing multimodal foundation models for text, voice, and video generation, powering consumer applications with millions of users. | AI-powered medicinal chemistry platform that accelerates drug design through synthesis-aware generative chemistry and retrosynthesis. |
| Pricing | ||
| Published price | From $0.30 / 1M input tokens Pay-as-you-go API. Flagship MiniMax-M3 text model: $0.30 per 1M input tokens and $1.20 per 1M output tokens (rate doubles above 512k-token context). Other models range roughly $0.… | Custom No public pricing; partnership/collaboration-based. PostEra engages pharma partners under drug-discovery deals (with Pfizer, Amgen and others) rather than a self-serve subscriptio… |
| Pricing model | Usage-based | Custom quote |
| Free options | No free plan · Free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2021 | 2019 |
| Team size | 501-1000 employees | 51-200 employees |
| Headquarters | Shanghai, China | Boston, MA |